Gregory J. Divis

Insider Reports History

Entity
Individual
Location
10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory J. Divis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVADEL PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 159K $1.56M $9.80 Dec 6, 2024 Direct
AVADEL PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 10K $98.2K $9.82 Dec 9, 2024 By Trust
Jaguar Health, Inc. Director Common Stock 12.1K $364 $0.03 May 18, 2022 Direct
AVADEL PHARMACEUTICALS PLC Chief Executive Officer, Director Stock Option (Right to Buy) 600K Feb 20, 2024 Direct
Jaguar Health, Inc. Director Restricted stock units 0 May 18, 2022 Direct

Insider Reports Filed by Gregory J. Divis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVDL AVADEL PHARMACEUTICALS PLC Dec 6, 2024 2 $99.7K 4 Dec 10, 2024 Chief Executive Officer, Director
AVDL AVADEL PHARMACEUTICALS PLC Feb 20, 2024 1 $0 4 Mar 4, 2024 Chief Executive Officer, Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 10, 2023 1 $132K 4 Aug 10, 2023 Chief Executive Officer, Director
AVDL AVADEL PHARMACEUTICALS PLC Jun 5, 2023 1 $0 4 Jun 5, 2023 Chief Executive Officer, Director
AVDL AVADEL PHARMACEUTICALS PLC May 27, 2022 1 $103K 4 May 31, 2022 Chief Executive Officer, Director
JAGX Jaguar Health, Inc. May 18, 2022 2 $0 4 May 18, 2022 Director
JAGX Jaguar Health, Inc. Mar 28, 2022 1 $0 4 Mar 30, 2022 Director
AVDL AVADEL PHARMACEUTICALS PLC Dec 7, 2021 1 $0 4 Dec 9, 2021 Chief Executive Officer, Director
JAGX Jaguar Health, Inc. May 18, 2021 2 $0 4 May 20, 2021 Director